Medical Devices

A Cambridge firm's novel intracoronary liquid biopsy is creating a high-resolution data map of heart disease, promising a new era of precision medicine.

Medicana Health Group aims for 25,000 HPV shots annually, stepping into a major public health gap. But can this private initiative overcome cost barriers?

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

PSG midfielder Vitinha joins Vichy, signaling a major play in the booming male grooming market where athletic performance and skincare are the new power couple.

NerView Surgical's NerveSense™ wins FACIT's top award, spotlighting a growing ecosystem making Ontario a global leader in oncology innovation.

BrioHealth Solutions gets an FDA nod for a trial of its BrioVAD, a miniaturized heart pump designed for children with advanced heart failure.

Clinuvel's SCENESSE® advances to a pivotal Phase III trial with a novel EMA-backed design, focusing on patient experience and visible results.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

Danish medtech giant reels after US Medicare policy changes gut the sales outlook for its Kerecis wound care unit, forcing a major financial revision.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.

In a landmark decision, the DEA has rescheduled medical cannabis, unlocking scientific research, slashing industry taxes, and reshaping patient access.

A novel alpha-radiation therapy, Alpha DaRT, begins European trials, offering a new path for pancreatic cancer patients with no other treatment options.

With a fresh $22M investment and a $110M valuation, MINISH Technology is bringing its enamel-preserving, 'No-Drill' veneer system to the United States.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

Gentherm reports a record $394M first quarter, beating estimates as its transformational Modine deal progresses and it enters new medical and home markets.

With its CMO and CSO now both recipients of the AHA's top honor, Cardiovascular Clinical Sciences signals a rare concentration of elite expertise.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

With a physician shortage deepening across the US, two international medical schools just placed 97% of their graduates into residencies, many in underserved areas.

Days before the NFL Draft, Heisman winner Fernando Mendoza launches a major fund with a $500K pledge to fight the disease that affects his mother.